Clinical Trial Update: Biological Response of Stage IV Knee Osteoarthritis to Serial 12.5% Dextrose [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 clinical trial evaluating the biological response to serial injections of 12.5% dextrose in Stage IV knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Dextrose 12.5% (Dextrose)

Snippet

Sponsor: Universidad Nacional de Rosario | Conditions: Knee Osteoarthritis | Phase 2, Phase 3 | Status: COMPLETED